Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DozQrLpG.js ...

For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...

Eli Lilly has announced results from the VIVID-2 open-label extension study, showing that most patients with moderately to ...

Queensland has the third highest prevalence of a debilitating bowel disease that impacts 180,000 Australians, costing ...

JACK FITZWATER has revealed how he thought his football career was in jeopardy when he was forced to visit the toilet 40 times a day. The defender hopes to help League One club Exeter topple ...

While the rising incidence is due in part to environmental factors including ultra-processed foods and smoking, the ...

No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.

Data presented at the 2025 Crohn’s and Colitis Congress PALI-2108 demonstrated to effectively reduce colitis symptoms in DSS mouse model without CNS toxicity associated with systemic exposure Company ...

Data presented at the 2025 Crohn's and Colitis Congress PALI-2108 demonstrated to effectively reduce colitis symptoms in DSS mouse model without CNS toxicity associated with systemic exposure Company ...

Dr. Gunn added, “Given QBECO SSI’s novel immunological mechanism and the growing interest in the role of senescence in the progression of aging and chronic disease, these data suggest that clearing ...